Event Q&A with Dr Danny Chu

Breaking the Silence: How Our Communities Can Beat Hepatitis B and Prevent Liver Cancer

Wednesday, August 20, 2025

7pm ET (6pm CT)

Hepatitis B patients get liver cancer 15x more often than others. But liver cancer due to hepatitis B is preventable. Learn from Dr. Danny Chu about reducing your liver cancer risk, keeping your liver healthy, and the latest treatments, including potential cures.

Featuring

Dr Danny Chu
Gastroenterologist

Dr. Danny Chu, MD, is a Clinical Instructor in the Department of Medicine at NYU Grossman School of Medicine in New York, NY.

Dr. Chu earned his medical degree from George Washington University School of Medicine in 1989 and completed a fellowship in Gastroenterology at St. Luke's-Roosevelt Hospital Center in 1994, followed by a fellowship in Hepatobiliary Medicine at Mount Sinai Medical Center in 1995. He became Board Certified in Gastroenterology in 2015.

Dr. Chu is a leader in the management and treatment of liver cancer patients and is also passionate about addressing health disparities in the Asian community. Dr. Chu has been serving liver cancer patients for more than 30 years.

 

The site content is provided for informational purposes only and does not intend to substitute professional medical advice, diagnosis, or treatment.
© 2025 CHMConnect™. All rights reserved.

Skip to content